TrialHuman vaccines & immunotherapeutics2026

Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial.

Sarang K Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.